SAN JOSE -- A Stanford University genetics professor has paid nearly $30 million in restitution after a judge determined that he misled investors in a now-dissolved biotechnology company he founded.

A prominent genetics professor at Stanford University in the US has paid $29 million to investors in Nuredis – a biotech that has now been wound up – after a California court found he ...

Tapping two Stanford University experts and $45 million from ... Related: Peninsula biotech lines up $70M to help make cancer drugs precise Stanford study targets fresh insights on convalescent ...

Former Stanford University President Marc Tessier-Lavigne is leading a who's-who of biotech players — including Stanford Nobel laureate Carolyn Bertozzi, former Food and Drug Administration ...

including the abrupt resignation of the celebrity scientist who led Stanford University and the implications of tornado damage at a Pfizer plant. Adam Feuerstein is a senior writer and biotech ...

Tessier-Lavigne, a neuroscientist and biotech entrepreneur ... 2023 Before he became Stanford’s president, Tessier-Lavigne served as president of Rockefeller University in New York, oversaw ...

Baker is a rising sophomore at Stanford University. At its daily student ... investigation found that as a neuroscientist and biotechnology executive, he had fostered an environment that led ...

David Botstein, an internationally acclaimed geneticist and chair of Stanford University's genetics department, will present a public lecture on "The Genome, Biotechnology and Cancer," Thursday, Nov.

By Stephanie Saul Following months of intense scrutiny of his scientific work, Marc Tessier-Lavigne announced Wednesday that he would resign as president of Stanford University after an ...